PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Hyacinth bean is identified as one of several groups of foods used in China with hypolipidaemic effects [PMID:24394619]
The bean is highlighted for its role in protecting against metabolic diseases through underlying molecular mechanisms [PMID:38961686]
Evidence summary
PubMed sources
- 1.PMID: 38961686 (2025) — An underutilized bean: hyacinth bean [Lablab purpureus (L.) sweet]: bioactive compounds, functional activity, and future food prospect and applications. · Journal of the science of food and agriculture
- 2.PMID: 22435478 (2009) — Morphological and reproductive characterization in hyacinth bean, Lablab purpureus (L.) sweet germplasm with clinically proven nutraceutical and pharmaceutical traits for use as a medicinal food. · Journal of dietary supplements
- 3.PMID: 38274205 (2023) — Evaluation of lablab bean [Lablab purpureus (L.) sweet] genotypes: unveiling superior pod yield, nutritional quality, and collar rot resistance. · Frontiers in nutrition
- 4.PMID: 40509468 (2025) — Comparing the Metabolic Characteristics of Hyacinth Bean (Lablab purpureus L.) Seeds from Five Local Varieties by UHPLC-QE HF HRMS. · Foods (Basel, Switzerland)
- 5.PMID: 24394619